Blog

On February 17, 2026, Vestal Point Capital disclosed in a Securities and Exchange Commission (SEC) filing that it sold 1,054,000 shares of Nuvalent (NASDAQ:NUVL), an estimated $103.93 million

Investing in a struggling company such as Rivian Automotive (NASDAQ: RIVN), which has seen its share price crater by more than 85% since going public back in 2021, can be extremely risky. But when a

nLIGHT (NASDAQ:LASR) Board of Directors member Raymond A. Link reported the sale of 25,404 shares of common stock in multiple open-market transactions from March 11, 2026 through March 13, 2026, for

On February 17, 2026, Vestal Point Capital disclosed a new position in Terns Pharmaceuticals (NASDAQ:TERN), acquiring 4,500,000 shares worth $181.80 million.

According to a U.S. Securities and

There were many changes to the tax code starting in the 2025 tax year. One of the biggest changes affects seniors. Older Americans ages 65 and up were given a generous new tax break that could

Shares of artificial intelligence (AI) cloud infrastructure provider CoreWeave (NASDAQ: CRWV) have had a wild ride since going public in March 2025. And while the stock is down significantly from

Cormorant Asset Management disclosed a buy of 2,361,260 shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) in its February 17, 2026 SEC filing, an estimated $27.86 million trade based on quarterly

Many cryptocurrency skeptics like to point to what they consider the lack of utility of such assets. One person who would disagree with that, at least in the case of Circle Internet Group's (NYSE:

Over the last year, Nebius Group (NASDAQ: NBIS) has emerged as a core pillar supporting artificial intelligence (AI) infrastructure. As hyperscalers accelerate data center build-outs, Nebius is

Intel (NASDAQ: INTC) stock had quite a Monday. Shares surged as much as 7.4% before giving it all back, closing where it started.

The early spike came as the broader semiconductor market rallied

On February 17, 2026, Cormorant Asset Management disclosed in a regulatory filing that it sold its entire stake in Arcellx (NASDAQ:ACLX), an estimated $63.63 million transaction based on

Is the Great Software Stock Rout over?

It's too soon to say, but some titles in the category enjoyed a bit of a comeback Monday. One was ServiceNow (NYSE: NOW), a specialist in optimizing IT

When it comes to investing, small investors may only have an amount of around $2,000 to either start a portfolio or add to their holdings. While that may not sound like a lot of money, some

The artificial intelligence (AI) craze has taken over the markets in an unbelievable way. Companies are spending incredible amounts of money on computing capacity. Advancements in this technology

One of the most captivating growth stocks to own in recent years has been that of electric vehicle (EV) maker Tesla (NASDAQ: TSLA). Its CEO, Elon Musk, is always focused on long-term growth

Shares of Tower Semiconductor (NASDAQ: TSEM) climbed on Monday after the manufacturer of analog integrated circuits announced a partnership with photonic networking upstart Oriole Networks.

Image

Nvidia (NASDAQ: NVDA) stock finished Monday up just 1.6% despite gaining as much as 4.8% earlier in the day. The S&P 500 gained 1%.

CEO Jensen Huang took the stage at the company's GTC conference

Devon Energy (NYSE: DVN) combines low-cost oil production, a proven capital return framework, and a transformative merger that makes it structurally larger and more durable. Shares are currently

An investment in crypto company BitMine Immersion Technologies (NYSEMKT: BMNR) is one of the top sideways plays on the value of Ethereum. So when the currency does well, as it has lately, investors

Image source: The Motley Fool.

Monday, Mar. 16, 2026 at 4:30 p.m. ET

Need a quote from a Motley Fool analyst? Email [email protected]

Continue reading

Source Fool.com

Cormorant Asset Management initiated a new position in Olema Pharmaceuticals (NASDAQ:OLMA), buying 2,750,000 shares worth $68.75 million in the fourth quarter, according to a February 17, 2026, SEC

CytomX Therapeutics (NASDAQ:CTMX), a biotech company that develops conditionally activated biologics for cancer treatment, closed Monday at $6.75, up 44.23%. The stock is jumping after releasing

Cormorant Asset Management disclosed a sale of 50,000 shares of Praxis Precision Medicines (NASDAQ:PRAX) in a February 17, 2026, SEC filing, with an estimated transaction value of $9.31 million

One of the biggest events for Nvidia (NASDAQ: NVDA) investors every year is the company's GPU Technology Conference (GTC). The event is the world's premier artificial intelligence (AI) conference

The Schwab U.S. Small-Cap ETF (NYSEMKT:SCHA) and iShares Morningstar Small-Cap ETF (NYSEMKT:ISCB) both offer broad, low-cost exposure to U.S. small-cap stocks, but differ in fund size, sector tilts